Matrine Enhances the Antitumor Efficacy of Chidamide in CTCL by Promoting Apoptosis
CONCLUSION: Our data have demonstrated chidamide combined with matrine to exhibit elevated antitumor activity in both CTCL cells and xenograft models of NOD/SCID mice, which may be a potential treatment option for CTCL.PMID:38571359 | DOI:10.2174/0115748928289036240318040756
Source: Recent Patents on Anti-Cancer Drug Discovery - Category: Cancer & Oncology Authors: Xinglan He Guanyu Wang Yimeng Wang Chunlei Zhang Source Type: research
More News: Cancer | Cancer & Oncology | China Health | Complementary Medicine | Cutaneous T cell lymphoma | Herbs | Lymphoma | Non-Hodgkin's Lymphoma | Skin | Study | T-cell Lymphoma